醋酸格拉替雷致药物性肝损伤并导致肝移植：一例报告
Drug-induced liver injury by glatiramer acetate leading to liver transplant: A case report.
作者信息
Amirkhani Nikan, Khalaji Amirmohammad, Alehossein Parsa, Safaei Masoomeh, Aletaha Najme, Miroliaee Arash
机构信息
School of Medicine Tehran University of Medical Sciences Tehran Iran.
Non-communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute Tehran University of Medical Sciences Tehran Iran.
出版信息
JGH Open. 2023 Jul 26;7(8):591-593. doi: 10.1002/jgh3.12938. eCollection 2023 Aug.
Glatiramer acetate (GA) is a widely used immune-modulating drug in relapsing multiple sclerosis (MS). Although a few cases of drug-induced liver injury during GA therapy have been reported earlier, herein we present the case of a 43-year-old woman with relapsing MS who experienced acute liver failure after GA therapy, ultimately leading to liver transplant.
醋酸格拉替雷（GA）是复发型多发性硬化症（MS）中广泛使用的免疫调节药物。尽管此前已有一些关于GA治疗期间药物性肝损伤的病例报道，但在此我们报告一例43岁复发型MS女性患者，其在接受GA治疗后发生急性肝衰竭，最终接受了肝移植。
Zotero 插件